THER

THERALINK TECHNOLOGIES by Theralink Technologies Inc. (THER)

About THERALINK TECHNOLOGIES by Theralink Technologies Inc. (THER)

Theralink Technologies, Inc. is a precision medicine company, which engages in the development of novel cancer immunotherapy products. It offers the reverse phase protein array technology platform that can quantify protein signaling to support oncology clinical treatment decisions and biopharmaceutical drug development. The company was founded on March 18, 2005 and is headquartered in Golden, CO.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
615,200
Dividend yield
0.00%
Volume
--
Avg. volume
27,011
P/E ratio
--

THERALINK TECHNOLOGIES by Theralink Technologies Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
615,200
Dividend yield
0.00%
Volume
--
Avg. volume
27,011
P/E ratio
--